Continuous daily injections of a cell-penetrating ARF peptides in HCCs in mice with FOXM1 activity has also been shown to inhibit tumor cell proliferation and angiogenesis and significantly increase apoptosis within the HCC region [43]. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.